We are pleased to announce that Vijay Yechoor, MD and the team headed by Lans Taylor, PhD, of the Drug Discovery Institute, have been awarded a National Institute of Diabetes and Digestive and Kidney Diseases R01 supplement. The grant is titled “Therapeutic strategies to test the mitigation of the cytokine storm syndrome and coagulopathy in patient cell-derived vLAMPS with type 2 diabetes and COVID19 infections”.
